Crestwood Advisors Group LLC Reduces Holdings in Danaher Corporation $DHR

Key Points

• Crestwood Advisors trimmed its stake in Danaher by 4.9% in the 4th quarter, selling 15,651 shares and leaving it with 301,000 shares worth about $68.9 million (≈1.1% of Crestwood's portfolio, its 24th largest holding).
• Wall Street sentiment is broadly positive with 18 Buys and 3 Holds, an average analyst rating of "Moderate Buy" and an average price target of $240.70 (analyst targets range mostly in the $232–$245 area).
• Danaher recently beat EPS expectations ($2.06 vs. $1.94) while revenue came in slightly below estimates, and the company announced a $0.40 quarterly dividend ($1.60 annualized, ~0.9% yield).

Crestwood Advisors Group LLC trimmed its stake in Danaher Corporation (NYSE:DHR - Free Report) by 4.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 301,000 shares of the conglomerate's stock after selling 15,651 shares during the period. Danaher accounts for about 1.1% of Crestwood Advisors Group LLC's investment portfolio, making the stock its 24th biggest holding. Crestwood Advisors Group LLC's holdings in Danaher were worth $68,905,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. JPL Wealth Management LLC purchased a new stake in shares of Danaher in the 3rd quarter worth about $25,000. Elevated Capital Advisors LLC purchased a new stake in shares of Danaher in the 4th quarter worth about $26,000. WFA of San Diego LLC purchased a new stake in shares of Danaher in the 2nd quarter worth about $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Danaher in the 3rd quarter worth about $27,000. Finally, Financial Life Planners purchased a new stake in shares of Danaher in the 3rd quarter worth about $32,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on DHR shares. Evercore raised their target price on shares of Danaher from $225.00 to $232.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 21st. Guggenheim dropped their target price on shares of Danaher from $275.00 to $235.00 and set a "buy" rating for the company in a research report on Wednesday, April 22nd. Weiss Ratings reiterated a "hold (c)" rating on shares of Danaher in a research note on Friday, March 27th. JPMorgan Chase & Co. decreased their price target on shares of Danaher from $275.00 to $245.00 and set an "overweight" rating for the company in a research note on Wednesday, April 22nd. Finally, Jefferies Financial Group reiterated a "buy" rating and issued a $245.00 price target on shares of Danaher in a research note on Tuesday, April 21st. Eighteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $240.70.

Insider Activity

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the company's stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 10.80% of the company's stock.

Danaher Stock Performance

Danaher stock opened at $175.55 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $124.25 billion, a P/E ratio of 33.95, a PEG ratio of 2.34 and a beta of 0.81. The stock's 50 day moving average is $191.25 and its 200 day moving average is $212.54. Danaher Corporation has a twelve month low of $172.06 and a twelve month high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm's quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.88 EPS. On average, equities research analysts predict that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher's payout ratio is 30.95%.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.